APA (7th ed.) Citation

Yarlagadda, S., Sheremeta, C., Cheung, S. W., Cuffe, A., Grounds, M. D., Smythe, M. L., & Noakes, P. G. (2025). Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse model. Skeletal Muscle, 15(1), 1. https://doi.org/10.1186/s13395-025-00379-1

Chicago Style (17th ed.) Citation

Yarlagadda, Sai, Chynna-Loren Sheremeta, Sang Won Cheung, Alison Cuffe, Miranda D. Grounds, Mark L. Smythe, and Peter G. Noakes. "Pharmacology and Macrophage Modulation of HPGDS Inhibitor PK007 Demonstrate Reduced Disease Severity in DMD-affected Muscles of the Mdx Mouse Model." Skeletal Muscle 15, no. 1 (2025): 1. https://doi.org/10.1186/s13395-025-00379-1.

MLA (9th ed.) Citation

Yarlagadda, Sai, et al. "Pharmacology and Macrophage Modulation of HPGDS Inhibitor PK007 Demonstrate Reduced Disease Severity in DMD-affected Muscles of the Mdx Mouse Model." Skeletal Muscle, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1186/s13395-025-00379-1.